BMS To Launch Novel Schizophrenia Therapy Cobenfy Within The Next Month

KarXT Came From $14bn Karuna Buy

 
• By Mandy Jackson
  
Face seen from the side. Brain problems. Degenerative disease. Bipolar disorder, illness, concept, double personality, schizophrenia.
Cobenfy has the first new antipsychotic mechanism of action in decades • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Leadership